Achieving a prominent position in the treatment of dermatological and chronic-degenerative pathologies, discovering and developing innovative solutions that are easily accessible to patients.
Becoming a recognised and respected company that provides practical and easy to apply responses to those seeking to improve their health and well-being.
Ensuring constant investment in our research and development activities so as to offer outstanding therapeutic solutions, including by means of partnerships.
Contributing to the progress of medicine, providing the right answers to the needs of doctors and guaranteeing ethical behaviour in our research and development, production, communication and sales activities.
Founded in 2009 but heir to an intense research and development activity since 2004, Freia Farmaceutici has established a world leadership position in developing plant-based therapeutic solutions for human health through its effective drug discovery and development processes, its intellectual property portfolio and regulatory and manufacturing expertise.
Particularly, over the years Freia has developed a specific knowledge about hemp plants.
Today Freia possesses, among few pharmaceutical companies in the world, an extensive knowledge as research, development, design, formulation of this plant in the agronomic, extraction and human health product manufacturing fields. All Freia’s activities create and aim to create new hemp varieties and hemp-derived products, free from THC and CBD. Over the years, Freia has pursued a precise strategy in intellectual property management and production, based on an integrated management of all components: proprietary raw materials, patents, trademarks and clinical evidence.
For its innovative business idea, Freia Farmaceutici was funded by Lombardy Region through SEED Fund – a Revolving Fund for financing new innovative Lombard companies.
Freia Farmaceutici has been awarded with the Seal of Excellence - Phase II by the European Commission under Horizon 2020 program. First company in Europe, Freia received, through Horizon 2020 program, a grant from the European Commission to finance the development of an innovative line of hemp-based products to support patients suffering from cachexia.
Freia Pharma LLC has been established to strengthen the company’s international presence and expand into the North American market.
Freia’s pharmaceutical laboratories manage the entire production process — from research and selection of raw materials to product formulation, manufacturing, packaging, and commercialization.
Since its foundation, Freia Farmaceutici has partnered with leading organizations across Europe, Asia, and the Americas to ensure the highest and most up-to-date quality standards.
Driven by continuous scientific and technological research, Freia Farmaceutici combines cutting-edge innovation with the excellence and craftsmanship of Italian manufacturing.